These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12917636)

  • 1. MDM2-ARF complex regulates p53 sumoylation.
    Chen L; Chen J
    Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar Arf sequesters Mdm2 and activates p53.
    Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
    Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
    Zhang Y; Xiong Y
    Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
    Tago K; Chiocca S; Sherr CJ
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
    Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
    Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARF function does not require p53 stabilization or Mdm2 relocalization.
    Korgaonkar C; Zhao L; Modestou M; Quelle DE
    Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
    Llanos S; Clark PA; Rowe J; Peters G
    Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
    Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
    Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 promotes ubiquitination and degradation of MDMX.
    Pan Y; Chen J
    Mol Cell Biol; 2003 Aug; 23(15):5113-21. PubMed ID: 12860999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
    Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
    Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MdmX inhibits ARF mediated Mdm2 sumoylation.
    Ghosh M; Weghorst K; Berberich SJ
    Cell Cycle; 2005 Apr; 4(4):604-8. PubMed ID: 15876864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation.
    Jackson MW; Lindstrom MS; Berberich SJ
    J Biol Chem; 2001 Jul; 276(27):25336-41. PubMed ID: 11297540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of MDMX by sumoylation.
    Pan Y; Chen J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):702-9. PubMed ID: 15907800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
    Zhang Y; Xiong Y; Yarbrough WG
    Cell; 1998 Mar; 92(6):725-34. PubMed ID: 9529249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.